Federal Supply Schedule 36F79725D0160
Award Date
7/15/25
Last Date to Order
7/14/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
Zyla Life Sciences US, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Scilex Pharmaceuticals Inc., a for-profit organization, on March 1, 2019. The contract has a ceiling value of $300,000.00 and an ultimate completion date of January 31, 2026. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
The Federal Supply Schedule contract, awarded to Zyla Life Sciences US, LLC (Egalet Corp Delaware), provides the Department of Veterans Affairs (VA) with access to a variety of pharmaceutical and hematology-related products. The contract has a ceiling value of $5,951,500.00 and a period of performance through July 14, 2025. Additionally, a Blanket Purchase Agreement (BPA) with a ceiling of $10,500,000.00 was established under the parent contract for the procurement of the drug product SPRIX. The...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency within the Department of Veterans Affairs. The contract was awarded to Metacel Pharmaceuticals LLC, a for-profit organization, on February 1, 2025 and has a period of performance through January 31, 2030. The contract has a ceiling value of $225,000.00 and is for the provision of "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS"...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Saptalis Pharmaceuticals, LLC, a for-profit limited liability company. The contract is a multiple-award vehicle under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance ending on March 31, 2025 and a ceiling value of $25,000.00. The contract aims to procure a range of pharmaceutical and...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...